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Structural and functional analyses of a glutaminyl
cyclase from Ixodes scapularis reveal
metal-independent catalysis and inhibitor binding
Glutaminyl cyclases (QCs) from mammals and Drosophila are
zinc-dependent enzymes that catalyze N-terminal pyroglutamate formation of numerous proteins and peptides. These
enzymes have been found to be critical for the oviposition
and embryogenesis of ticks, implying that they are possible
physiological targets for tick control. Here, 1.10–1.15 Å
resolution structures of a metal-independent QC from the
black-legged tick Ixodes scapularis (Is-QC) are reported. The
structures exhibit the typical scaffold of mammalian QCs but
have two extra disulfide bridges that stabilize the central
-sheet, resulting in an increased thermal stability. Is-QC
contains 0.5 stoichiometric zinc ions, which could be
removed by 1 mM EDTA. Compared with the Zn-bound
form, apo-Is-QC has a nearly identical active-site structure
and stability, but unexpectedly possesses significantly
increased QC activities towards both synthetic and physiological substrates. Enzyme-kinetic analysis revealed that apoIs-QC has a stronger substrate-binding affinity, suggesting that
bound zinc interferes with substrate binding during catalysis.
The structures of Is-QC bound to the inhibitor PBD150
revealed similar binding modes to both forms of Is-QC, with
the exception of the inhibitor imidazole ring, which is
consistent with the comparable inhibition activities of the
inhibitor towards both forms of Is-QC. These findings have
implications for the design of new QC inhibitors.
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PDB references: Zn-Is-QC,
4mhn; apo-Is-QC, 4mhp;
Zn-Is-QC–PDB150, 4mhy;
Zn-Is-QC–PDB150, 4mhz

1. Introduction
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Glutaminyl cyclases (QCs; EC 2.3.2.5) catalyze the cyclization
of glutaminyl or glutamyl residues to form pyroglutamate
(5-oxoproline; pGlu) at the N-terminus of numerous
hormones, cytokines and other secretory peptides (Fischer &
Spiess, 1987; Busby et al., 1987; Schilling et al., 2004). The
formation of pGlu is believed to protect these bioactive
proteins and peptides from exopeptidase degradation and, in
numerous cases, such as thyrotropin-releasing hormone and
some cytotoxic ribonucleases, to endow them with a functional
conformation (Goren et al., 1977; Lou et al., 2006). QCs can be
classified into two types on the basis of their distinct molecular
structures and protein stabilities: type I QCs have been
identified in plants and some bacteria (Wintjens et al., 2006;
Huang et al., 2010), while type II QCs have so far been found
in humans, some mammals and insects (Busby et al., 1987;
Huang, Liu, Cheng et al., 2005; Schilling et al., 2007). Recent
studies have indicated that QCs are emerging drug targets for
the treatment of Alzheimer’s disease and some inflammatory
disorders, such as septic arthritis (Schilling et al., 2008; Nussbaum et al., 2012; Hellvard et al., 2013). These studies were
motivated by the findings that human secretory QC is able
to catalyze N-terminal pGlu formation of several amyloid
doi:10.1107/S1399004713033488
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-peptides, leading to enhanced aggregation and neurotoxicity
of these peptides (Schilling et al., 2008; Cynis, Scheel et al.,
2008; Schlenzig et al., 2009), and that the Golgi-resident QC is
able to catalyze pGlu formation of monocyte chemoattractant
proteins, a crucial step for the migration and infiltration of
monocytes in some inflammatory conditions (Cynis, Rahfeld et
al., 2008; Cynis et al., 2011; Chen et al., 2012).
Schilling, Niestroj et al. (2003) have proposed that human
secretory QC is a metalloenzyme based on its time-dependent
inhibition by several metal-chelating agents and imidazole
derivatives as well as the reactivation of the inactive ‘apoenzyme’ by the addition of metal. A couple of years later, the
recombinant human and mouse QCs were shown to contain
stoichiometric amounts of zinc (Huang, Liu & Wang, 2005;
Schilling et al., 2005). Moreover, the crystal structures of
human QCs have revealed a bound zinc ion coordinated by
three conserved residues (Huang, Liu, Cheng et al., 2005;
Huang et al., 2011). Therefore, type II QCs are commonly
believed to be zinc-dependent enzymes. Along these lines, a
series of compounds derived from imidazole have been
developed as QC inhibitors, such as PBD150 (Buchholz et al.,
2006, 2009), which is a potent inhibitor of human QCs, with a
Ki value of 0.1 mM towards the secretory form. The structures of human QCs in complex with imidazole derivatives
have confirmed the binding between the inhibitor imidazole
ring and the active-site zinc of QCs (Huang et al., 2011).
Furthermore, oral administration of PBD150 in transgenic
mouse models of Alzheimer’s disease resulted in significantly
reduced depositions of A3(pGlu)-40/42 in the brain (Schilling et
al., 2008), leading to improved learning and memory in the
mice. Recently, Hellvard et al. (2013) reported that some QC
inhibitors were able to significantly delay the onset of clinical
signs of arthritis in a septic arthritis mouse model. These
findings imply that QC inhibitors may be potential drugs for
the treatment of Alzheimer’s disease and some inflammatory
disorders.
To date, however, several lines of results argue against the
requirement for a metal in QCs. For example, (i) recombinant
human QC expressed in Drosophila S2 cells showed 0.3
moles of zinc per mole of enzyme, but possessed an enzymatic
activity that was comparable to those of QC samples produced
by Pichia and Escherichia coli cells, which were shown to
contain stoichiometric amounts of zinc (Huang, Liu & Wang,
2005; Booth et al., 2004; Schilling et al., 2002); (ii) the recombinant human and mouse QCs appeared to be refractory to
the strong metal chelator EDTA even at concentrations above

20 mM (Schilling, Niestroj et al., 2003; Schilling et al., 2005);
and (iii) the enzyme activity of porcine QC partially purified
from pituitary extracts was shown to be enhanced around
twofold by the addition of 10 mM EDTA (Busby et al., 1987).
These phenomena are very unusual in the families of zincdependent enzymes (Auld, 1995). Because no reports have
described the exact quantity of zinc from QCs treated with
EDTA and other metal-chelating agents, and the structure of
an inactive ‘apo form’ of a QC is not yet available, the role of
zinc in QC catalysis still remains controversial.
More recently, Adamson et al. (2013) reported that QCs are
functionally linked to the bloodmeal uptake of ticks. Knockdown of tick QC by RNA interference resulted in remarkably
attenuated oviposition and embryogenesis, which is most
likely to be attributable to improper pGlu formation and thus
a shorter half-life of several pGlu-modified neuropeptides,
such as corazonin, sulfakinin and periviscerokinin, in the ticks
(Neupert et al., 2009). Since ticks, especially the black-legged
tick Ixodes scapularis, are important vectors of some human
pathogens such as Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti (Burgdorfer et al., 1982; Telford
et al., 1996; Rodgers & Mather, 2007), this finding implies that
QCs are potential physiological targets for tick control to
prevent the spread of tick-borne diseases. In the present study,
we report the production and atomic resolution crystal
structures of a metal-independent QC from I. scapularis (IsQC). Structural and ICP-MS analyses revealed that Is-QC
contains 0.5 stoichiometric zinc ions, which could readily be
removed by EDTA at low-millimolar concentrations. Unexpectedly, apo-Is-QC was shown to possess a significantly
increased QC activity compared with the Zn-bound form,
despite having a nearly identical active-site structure. The
enzyme-kinetic properties and thermal stabilities of both zincbound and apo-Is-QC were analyzed, which suggest that the
presence of zinc was owing to nonspecific binding. We further
analyzed the inhibition potency of imidazole derivatives
towards both forms of Is-QC and determined the structures of
both forms of Is-QC bound to PBD150.

2. Materials and methods
2.1. Materials

Chemicals were purchased as follows: l-glutaminyl
2-naphthylamide from Bachem (Weil am Rhein, Germany);
2-naphthylamide, N-!-acetylhistamine, 1,10-phenanthroline
and dipicolinic acid from Sigma–
Aldrich (St Louis, Missouri, USA);
1-benzylimidazole from Fluka (St Louis,
Missouri, USA). Human pyroglutamyl
aminopeptidase I (PAP I) was prepared
as described previously (Huang et al.,
2008). The peptides [Gln1]-corazonin,
[Gln1]-sulfakinin and [Gln1]-periviscerokinin were synthesized by standard
Figure 1
FMOC peptide chemistry (Huang, Liu
Schematic representation of the expression construct for Is-QC. Trx, thioredoxin-fusion protein;
TCS, thrombin cleavage site; ECS, enterokinase cleavage site; FCS, factor Xa cleavage site.
& Wang, 2005). The QC inhibitor
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PBD150 was chemically synthesized according to a previous
report (Buchholz et al., 2006). All other chemicals were of
analytical or HPLC grade.

human secretory QC (sQC) was performed according to a
previous protocol (Huang, Liu & Wang, 2005).
2.3. Enzyme-activity assay

2.2. Protein expression and purification

The cDNA encoding I. scapularis QC (nucleotide entry
XM_002415508.1) was obtained previously (Adamson et al.,
2013). The cDNA fragment covering the putative catalytic
domain (Trp25–Leu353) of the enzyme was amplified and
inserted into a thioredoxin-fusion expression vector via
HindIII and XhoI cloning sites as described previously
(Huang, Liu & Wang, 2005). The resulting construct contained
a thioredoxin-fusion protein, two 6His tags and a factor Xa
cleavage site upstream of the Is-QC coding region (Fig. 1). The
vector was transformed into E. coli BL21(DE3) CodonPlusRIL cells (Stratagene, La Jolla, California, USA). The bacteria
were grown in Luria–Bertani medium containing ampicillin
(100 mg ml1) and chloramphenicol (34 mg ml1) at 37 C until
the cell density reached an A600 of 0.8. The cultures were
induced with 1 mM isopropyl -d-1-thiogalactopyranoside for
18–20 h at 20 C. The cells were then harvested by centrifugation (8983g for 30 min at 4 C) followed by freezing at
80 C. Frozen bacterial pellets were resuspended in lysis
buffer (50 mM Tris–HCl pH 7.8 containing 150 mM NaCl and
10 mM imidazole) and the cells were lysed using a cell
disruptor (Constant Systems, Kennesaw, Georgia, USA). The
cell lysate was clarified by centrifugation (104 630g for 60 min
at 4 C) and the supernatant was loaded onto a nickel–nitrilotriacetic acid column (Amersham Biosciences, Piscataway,
New Jersey, USA) pre-equilibrated with buffer A (50 mM
Tris–HCl pH 7.8, 150 mM NaCl, 10 mM imidazole, 5%
glycerol). The column was washed with the same buffer and
the bound materials were eluted with a linear gradient of 0–
100% buffer B (50 mM Tris–HCl pH 7.8, 150 mM NaCl,
300 mM imidazole, 5% glycerol). The fractions containing
thioredoxin-fusion Is-QC were pooled and were digested with
factor Xa (0.3 units ml1; Novagen, Darmstadt, Germany). To
minimize interference from the imidazole present in the
protein solution, the digestion reaction was carried out in a
dialysis bag and the imidazole was removed by dialysis against
buffer C (50 mM Tris–HCl pH 7.8, 150 mM NaCl, 5%
glycerol) at 25 C for 18–20 h. Subsequently, because of the
relatively high content (4.9%) of histidine residues in Is-QC,
the cleaved Is-QC products were isolated from the digest on
a second nickel–nitrilotriacetic acid column pre-equilibrated
with buffer C. The bound Is-QC was eluted with a linear
gradient of 0–100% buffer D (50 mM Tris–HCl pH 7.8,
150 mM NaCl, 40 mM imidazole, 5% glycerol). The protein
was concentrated and further desalted on a Sephacryl S-100
column (Amersham Biosciences) eluted with buffer E (50 mM
Tris–HCl pH 7.8 containing 5% glycerol). The purified Is-QC
was shown to be homogeneous as judged by SDS–PAGE with
Coomassie Blue staining. The D144A and D238A mutants
were constructed using KOD Hot Start DNA Polymerase
(Novagen). In addition, the expression and purification of
Acta Cryst. (2014). D70, 789–801

The enzymatic activity of recombinant Is-QC was evaluated
at 25 C using the fluorescent substrate l-glutaminyl 2-naphthylamide (Gln-NA) as described previously (Huang et al.,
2008). The 100 ml reaction mixture contained 300 mM fluorogenic substrate, 0.2 units of the auxiliary enzyme human
PAP I (where one unit is defined as the amount that hydrolyzes 1 mmol of pGlu-NA per minute under the same
conditions) and an appropriately diluted aliquot of recombinant Is-QC in 50 mM Tris–HCl pH 8.0 with 5% glycerol. The
excitation and emission wavelengths were set to 320 and
410 nm, respectively. The reaction was initiated by the addition of Is-QC. Enzymatic activity was determined from the
amount of released NA and was calculated using a standard
curve for NA under the same assay conditions. The
measurements were made using a Synergy H4 microplate
reader (BioTek, Winooski, Vermont, USA).
The activity of QC towards the physiological substrates of
I. scapularis was analyzed based on the time-dependent
change of the elution profile from reversed-phase HPLC as
described previously (Huang, Liu & Wang, 2005). Briefly, for
each individual substrate, a 30 ml reaction mixture containing
0.1 mM Is-QC and 1 mM substrate in 50 mM Tris–HCl pH
8.0 was incubated at 25 C for 5–180 min in the absence or
presence of 20 mM EDTA. Subsequently, a 20 ml aliquot of the
mixture was subjected to HPLC analysis on a Thermo UltiMate 3000 liquid chromatograph using a C18 column (Thermo
Fisher, Waltham, Massachusetts, USA). The bound materials
were eluted with a linear gradient of 0–100% acetonitrile
containing 0.1% TFA. The elution of the peptides was monitored by the absorbance at 214 nm and the pGlu-containing
product was identified by ESI-LC-MS/MS analysis.
2.4. Enzyme-kinetic assay

The kinetic constants were determined at pH 8.0 at 25 C
using the substrate Gln-NA as described previously (Huang
et al., 2008). The reaction was initiated by adding Is-QC (final
concentration of 43 nM) to the 100 ml reaction mixture. The
initial rate was measured with less than 10% substrate
depletion for the first 2–12 min. Since a weak substrate inhibition was observed, the kinetic parameters Km, V and Ki were
evaluated by fitting the equation v0 = Vmax[S]/(Km + [S] + [S]2/
Ki) to the initial velocity data by nonlinear regression using
the KaleidaGraph software (Synergy Software, Reading,
Pennsylvania, USA), where v0 is the initial velocity, Vmax is the
limiting rate, [S] is the substrate concentration, Km is the
Michaelis constant and Ki is the inhibition constant. Correlation coefficients of better than 0.995 were obtained throughout
the fittings. The substrate concentrations used were in the
range 1–240 mM. The kcat values were calculated from Vmax/
[E] according to the enzyme concentration determined from
the UV absorbance at 280 nm (" = 46 785 M1 cm1) in the
presence of 6.0 M guanidinium chloride. Therefore, the kcat
Huang et al.
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values reported below represent
minimal estimates based on the
assumption that the enzyme active-site
concentration is equivalent to the
concentration of the protein.
2.5. Inhibitor assay

The inhibition activity of metalchelating agents and imidazole derivatives was evaluated according to a
previous report (Huang et al., 2011).
Briefly, the reaction mixture contained
300 mM Gln-NA and 0.2 units of
human PAP I as described above. Is-QC
was first incubated with the inhibitor at
25 C for 30 min and the enzyme–inhibitor mixture was then added to the
reaction mixture to initiate the cyclization reaction. The final concentration of
Is-QC was 45 nM. The IC50 values
were obtained by fitting the initial
reaction rate versus the inhibitor
concentrations using KaleidaGraph. Ki
values were calculated according to the
equation IC50 = Ki(1 + [S]/Km) (Segel,
1993), where [S] is the substrate
concentration and Km is the Michaelis–
Menten constant.
2.6. Metal analysis

Table 1
Data-collection and refinement statistics.
These crystals belonged to space group P212121 and the asymmetric unit comprises one QC molecule.
Values in parentheses are for the highest resolution shell.

Data collection
Resolution (Å)
Unit-cell parameters (Å)
a
b
c
Total observations
Unique reflections
Multiplicity
Completeness (%)
hI/(I)i
Rmerge (%)
Refinement
Resolution (Å)
Reflections [>0(F)] (working/test)
R factor/Rfree
R.m.s.d.
Bond lengths (Å)
Angles ( )
No. of atoms
Protein
Inhibitor
Zinc ion
Water
Average B factor (Å2)
Protein
Inhibitor
Zinc ion
Water
Ramachandran plot, residues in (%)
Most favoured regions
Additionally allowed regions
Generously allowed regions
Disallowed regions
PDB code

The metal contents of the Is-QCs
and human sQC were determined by
inductively coupled plasma mass spectrometry (ICP-MS). For each analysis,
100 ml sample was pipetted into 3 ml
ultrapure nitric acid in a microwave tube. The solution was
heated in a microwave oven for 15 min to reach 200 C. The
sample was held at 200 C for 15 min and then cooled to room
temperature. Subsequently, the digested sample was diluted
with 2%(v/v) nitric acid to 25 ml and subjected to ICP-MS
analysis. Measurement of the amount of metal was made using
an ICP-MS X series II (Thermo Fisher, Waltham, Massachusetts, USA), with direct nebulization, a normal mode of
operation and an optimized condition consisting of an X-series
skimmer cone with a Platinum sampler cone. The extraction
voltage was 35 V with an RF power of 510 W, a focus voltage
of 4.5 V and a nebulizer gas-flow rate of 1.04 l min1. The
dwell times were 10 ms, and 100 sweeps were required for each
replicate, with five replicates every sample.
2.7. Thermal stability

The thermal stability was evaluated using SYPRO Orange
dye (Invitrogen, Karlsruhe, Germany). Samples were
prepared in 96-well plates and the experiments were
conducted in 50 mM Tris–HCl pH 8.0. For each well in the
plates, the 100 ml solution contained 0.20–0.23 mg ml1

792
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Zn-Is-QC

Apo-Is-QC

Zn-Is-QC–
PBD150

Apo-Is-QC–
PBD150

30–1.15
(1.19–1.15)

50–1.10
(1.14–1.10)

30–1.38
50–1.95
(1.43–1.38)
(2.02–1.95)

55.28
71.38
80.08
793696
112442 (11084)
7.1 (5.8)
99.6 (99.3)
43.9 (2.6)
5.6 (79.7)

55.39
71.15
80.12
759300
128122 (12774)
5.9 (5.7)
99.5 (100.0)
38.8 (2.8)
5.4 (77.7)

54.98
71.08
80.07
359056
64300 (6353)
5.6 (5.5)
99.1 (99.5)
31.3 (2.8)
7.1 (73.2)

55.26
71.44
80.25
83869
21418 (2102)
3.9 (3.7)
89.9 (90.4)
9.5 (1.9)
13.2 (75.4)

30–1.15
101091/5632
0.162/0.181

30–1.10
115164/6434
0.165/0.186

30–1.38
57726/3259
0.153/0.184

50–1.95
14875/843
0.166/0.221

0.005
1.125

0.005
1.131

0.006
1.169

0.012
1.530

2665

2665

2656
22

1
381

427

2650
22
1
334

16.1

14.4

20.5
26.6

14.8
27.0

25.9

16.1
19.5
12.2
27.7

30.0

90.1
9.6
0.3
0
4mhn

90.1
9.6
0.3
0
4mhp

91.0
8.7
0.3
0
4mhy

89.0
10.7
0.3
0
4mhz
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protein sample with SYPRO Orange dye added at a concentration of 5. The dye was originally delivered as a 5000
solution in 100%(v/v) DMSO and was first diluted into a 500
solution using 50 mM Tris–HCl pH 8.0 before adding the
sample. The fluorescence was recorded on a CFX Connect
real-time PCR system (Bio-Rad, Hercules, California, USA)
and was analyzed using the CFX Manager software. Data were
collected at 1 C intervals ranging from 25 to 95 C. The melting
temperature (Tm) was determined as the maximum of the first
derivative of the melting curves. Furthermore, to measure the
residual enzymatic activity at different thermal conditions, QC
samples in 50 mM Tris–HCl pH 8.0 were incubated at 25, 30,
35, 40, 45, 50, 55 or 60 C for 10 min and then cooled to room
temperature. The QC activities were determined as described
above, and the percentage residual activity at each temperature was calculated based on the activity at 25 C as 100%.
2.8. Crystallization and X-ray data collection

Purified Is-QC in 50 mM Tris–HCl with 5% glycerol pH 7.8
was concentrated to 8.5 mg ml1 using an Ultracel 10K
centrifugal filter (Millipore, Billerica, Massachusetts, USA).
Acta Cryst. (2014). D70, 789–801
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An initial crystallization screening of 900 conditions was
performed at the Core Facilities for Protein Structural
Analysis in Academia Sinica, Taipei, Taiwan. The crystals
were grown at 20 C by the sitting-drop vapour-diffusion
method. The final crystallization condition was 10%(w/v) PEG
8000, 8%(v/v) ethylene glycol, 0.1 M HEPES pH 7.5. Is-QC
was mixed with an equal volume of the crystallization solution,
and rod-like crystals with dimensions reaching 0.1  0.1 
0.2 mm appeared within 5–8 d. High-resolution X-ray
diffraction data were collected on beamline 13C1 of the
National Synchrotron Radiation Research Center, Hsinchu,
Taiwan and on beamline 4.2.2 of the Advanced Light Source
at Lawrence Berkeley National Laboratory, Berkeley, California, USA. Before being mounted on the goniometer, the
crystals were briefly soaked in reservoir solution containing
15%(v/v) glycerol as a cryoprotectant. All diffraction data
were processed and scaled with the HKL-2000 package
(Otwinowski & Minor, 1997). The datacollection statistics are listed in Table 1.
For the structures of Is-QCs bound to
PBD150, the crystals were soaked in
mother liquor containing 5 mM
PBD150 at 20 C for 3–5 d.

remaining data with F > 0 as a working data set. The parameters for ideal protein geometry of Engh and Huber were
used during refinement (Engh & Huber, 1991). Subsequently,
several rounds of model adjustment with Coot and refinement
with REFMAC5 were performed using a 1.15 Å resolution
data set to improve the quality and completeness of the
structure. The well ordered water molecules and one zinc ion
were located with Coot. Finally, the refinement converged at a
final R factor and Rfree of 0.162 and 0.181, respectively, in the
30–1.15 Å resolution range. The stereochemical quality of the
refined structure was checked with the program PROCHECK
(Laskowski et al., 1993). The final refinement statistics are
listed in Table 1. The initial difference Fourier maps for the
structures of apo-Is-QC and the PBD150-bound Is-QCs were
obtained employing the refined structure of Zn-Is-QC. The
molecular figures were produced with PyMOL (Schrödinger,
New York, USA).

2.9. Structure determination and
refinement

The crystal structure of Is-QC was
solved by the molecular-replacement
method with the program MOLREP
(Vagin & Teplyakov, 2010), using the
published structure (PDB entry 2afm;
Huang, Liu, Cheng et al., 2005) of
human sQC as a search model and a
2.2 Å resolution data set for recombinant Is-QC (Zn-Is-QC) which was
collected using an FR-E+ generator
equipped with an R-AXIS HTC imageplate detector at the Institute of Biological Chemistry, Academia Sinica,
Taipei, Taiwan. Only one clear solution
for the translation function indicated
the presence of one Is-QC molecule in
the asymmetric unit. On the basis of the
initial phase obtained from the molecular-replacement search, 90% of the
model was automatically traced into the
electron-density map with ARP/wARP
(Perrakis et al., 1999) and the remainder
was manually built with Coot (Emsley &
Cowtan, 2004). The resulting model was
subjected to computational refinement
with
the
program
REFMAC5
(Murshudov et al., 2011). Throughout
refinement, a randomly selected 5% of
the data was set aside as a free data set,
and the model was refined against the
Acta Cryst. (2014). D70, 789–801

Figure 2
Enzymatic activity of Is-QC and its modulation by metal-chelating agents. (a) Activities of Zn-IsQC (purple) and apo-Is-QC (blue) and comparison with the activity of human sQC (orange). The
activities  SD were calculated from three independent experiments. (b) Enzyme-kinetic analysis of
Zn-Is-QC and apo-Is-QC. The typical result of three experiments is presented. (c) Activities of
Zn-Is-QC and apo-Is-QC in the presence of EDTA, dipicolinic acid (Dipi) or 1,10-phenanthroline
(Phen). Before addition to the reaction mixture, the QC samples were pre-incubated with the metalchelating agents at the indicated concentrations for 30 min. The results were calculated as residual
activities  SD from three independent experiments. (d) Restoration of Is-QC activity. Columns 1, 4
and 7: Zn-Is-QC was passed through a Sephacryl S-100 size-exclusion column in the presence of 5
and 1 mM 1,10-phenanthroline and 5 mM dipicolinic acid, respectively, and the QC activities of the
resulting Is-QC samples were analyzed. Columns 2, 5 and 8: the Is-QC samples in columns 1, 4 and
7, respectively, were re-passed through a second Sephacryl S-100 column to remove the metalchelating agents and the QC activities of the resulting samples were analyzed. Columns 3, 6 and 9:
the Is-QC samples in columns 2, 5 and 8 were analyzed for QC activity in the presence of 1 mM
EDTA. All enzymatic activity assays were performed at 25 C in 50 mM Tris–HCl pH 8.0 using the
fluorescent substrate Gln-NA.
Huang et al.
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Table 2

added during the last purification
step by size-exclusion chromatoThe results are means  SD from three experiments. ND, not detectable. —, not determined.
graphy the enzymatic activity
increased by 55%, indicating
Metal-to-enzyme molar ratio  100
that
EDTA could stimulate the
QC sample
Zn
Ca
Mn
Fe
Co
Cu
Ni
Cd
activity of Is-QC. Similar results
Is-QC
51.6  1.4 8.6  0.3 0.15  0.01 2.3  0.1 ND
8.3  0.4 5.4  0.2 ND
were obtained when the enzyme
Is-QC + 1 mM EDTA 14.2  0.7 4.2  0.2 0.58  0.02 2.7  0.1 0.12  0.01 ND
ND
ND
and relevant materials in the QC
Is-QC + 10 mM EDTA 8.5  0.3 —
—
—
—
—
—
—
activity assay were treated with
Human sQC
98.2  3.4 3.2  0.2 1.2  0.1
1.9  0.1 ND
ND
3.8  0.1 ND
the metal-chelating resin Chelex100 at a concentration of 100 g
per litre of sample (data not shown). ICP-MS analysis
3. Results
revealed a stoichiometry of 0.5 mol of zinc per mole of
3.1. Protein production and enzymatic activity
enzyme for recombinant Is-QC (Zn-Is-QC); the zinc content
The segment Trp25–Leu353 of I. scapularis QC (Is-QC),
was reduced to 0.1 mol per mole of enzyme on the addition
which contains the putative catalytic domain of the enzyme,
of 1–10 mM EDTA (apo-Is-QC) (Table 2). In contrast, human
was overexpressed in E. coli cells and purified to nearsQC showed a nearly equimolar amount of zinc, consistent
homogeneity. The purified enzyme showed a QC activity that
with our previous data determined by the atomic absorption
was 1.2-fold stronger than the activity of human secretory
method (Huang, Liu & Wang, 2005). Indeed, the crystal
QC (sQC; Fig. 2a). Unexpectedly, when 1 mM EDTA was
structure of apo-Is-QC, as described below, demonstrated that
the zinc was effectively removed by 1 mM EDTA. Enzymekinetic analysis revealed that Zn-Is-QC has kcat and Km values
of 8.8  0.8 s1 and 21.8  3.5 mM, respectively, while those
for apo-Is-QC were 6.9  0.2 s1 and 8.8  0.6 mM, respectively (Fig. 2b), implying that the bound zinc interfered with
substrate binding during catalysis.
Moreover, although EDTA displayed a stimulatory effect,
the heterocyclic metal-chelating agents 1,10-phenanthroline
and dipicolinic acid showed strong inhibitory activities
towards Zn-Is-QC, with Ki values in the low- and mediummicromolar ranges, respectively (Fig. 2c and Table 3). Interestingly, similar inhibition effects were also observed towards
apo-Is-QC. In addition, once the metal-chelating agents had
been removed by size-exclusion columns, a large portion of
the QC activity could be restored (Fig. 2d, columns 2, 5 and 8)
and the activities were further enhanced by adding 1 mM
EDTA (Fig. 2d, columns 3, 6 and 9). These findings strongly
suggest that the inhibition by the heterocyclic metal-chelating
agents is owing to reversible binding of the chelators to Is-QC
rather than zinc depletion.
Metal contents of Is-QC and human sQC analyzed by ICP-MS.

3.2. Efficacy towards the physiological substrates of
I. scapularis

Figure 3
Efficacy of Is-QC towards the physiological substrates of I. scapularis.
Characterization of the cyclization rates of (a) [Gln1]-sulfakinin
(sequence QDDDYGHMRF), (b) [Gln1]-corazonin (QTFQYSRGWTN)
and (c) [Gln1]-periviscerokinin (QGLIPFPRV). All reactions were
carried out at 25 C in 50 mM Tris–HCl pH 8.0 in the presence (+) or
absence () of Zn-Is-QC, as described in x2. Progress at the indicated
time intervals was monitored by reverse-phase HPLC, and the glutaminyl
peptides and the resulting pyroglutamyl [pGlu1] products were confirmed
by ESI-LC-MS/MS analysis. The numbers below the lines indicate the
elution time (in minutes), whereas the other numbers indicate incubation
times (in minutes). In the right panels of the figure, EDTA was added to
the reaction mixtures to a final concentration of 20 mM to remove the
bound zinc in Is-QC.
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Apparently, as revealed by the time-dependent change in
the HPLC elution profiles (Fig. 3), Is-QC was able to convert
the three physiological substrates [Gln1]-sulfakinin, [Gln1]corazonin and [Gln1]-periviscerokinin to their expected pGlucontaining products. Furthermore, the enzymatic activity of
Is-QC was significantly increased by the addition of 20 mM
EDTA (Fig. 3, right panels). On close analysis of the elution
profiles, it is noteworthy that the cyclization rates of [Gln1]corazonin and [Gln1]-periviscerokinin were significantly faster
than that of [Gln1]-sulfakinin. In addition, a slightly faster rate
was observed for [Gln1]-periviscerokinin than for [Gln1]corazonin. These results suggest that Is-QC prefers substrates
with neutral or hydrophobic amino-acid residues at the second
Acta Cryst. (2014). D70, 789–801
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Figure 4
Crystal structures of Is-QC. (a) Overall structure of Zn-Is-QC shown as a ribbon diagram. The amino-acid sequences corresponding to the nine -helices
(1–9), eight -strands (1–8) and four 310-helices can be seen in Fig. 5. The bound zinc ion is shown as a grey ball. The zinc-coordinated amino-acid
residues (Asp144, Glu184 and His322) and water molecule are shown as yellow sticks and a red ball, respectively. The two extra disulfide bridges, as
described in the text, are also shown as yellow sticks. (b) A close-up view of the zinc-binding environment of Zn-Is-QC. The 2.5 2Fo  Fc electrondensity map, calculated with a zinc-free model of Is-QC, is overlaid on the final refined structure. The zinc-coordinated residues and water molecule are
labelled. (c) A close-up view of the metal-binding site of apo-Is-QC. The 2Fo  Fc electron-density map, contoured at the 2.5 level, is also shown. Note
that electron density for zinc is not visible, and a new hydrogen bond between Glu184 O"2 and His322 N"2 is formed with the distance indicated. (d)
Superimposition of the metal-binding sites in Zn-Is-QC (yellow) and apo-Is-QC (green). The zinc ion in Zn-Is-QC is shown as a grey ball.

Table 3
Inhibition of zinc-bound and apo-Is-QCs by heterocyclic metal-chelating
agents and imidazole derivatives.
Assays were performed at 25 C in 50 mM Tris–HCl pH 8.0 using l-glutaminyl
2-naphthylamide as the substrate. The results are means  SD from three
experiments.
Ki value (mM)
Compound

Zn-Is-QC

Apo-Is-QC

Human sQC†

1,10-Phenanthroline
Dipicolinic acid
PBD150
1-Benzylimidazole
N-!-Acetylhistamine

3.45  0.59
36.8  4.3
0.342  0.038
10.2  0.9
14.2  1.7

2.88  0.36
32.4  4.9
0.134  0.005
1.48  0.16
4.53  1.22

0.095
0.607
1.698

† Data are taken from the previous report (Huang et al., 2011).

and third positions, rather than negatively charged residues.
Indeed, similar substrate specificities were observed for
human, mouse and Drosophila QCs (Schilling, Manhart et al.,
2003; Schilling et al., 2005, 2007), presumably reflecting the
hydrophobic substrate-binding pocket near the catalytic
centres of these enzymes.
3.3. Crystal structures of Is-QC

The crystals of Zn-Is-QC and apo-Is-QC grown at pH 7.5 as
described in x2 belonged to space group P212121, with one IsQC molecule in the asymmetric unit. The crystal structures
Acta Cryst. (2014). D70, 789–801

were solved by the molecular-replacement method and were
refined to 1.10–1.15 Å resolution (Table 1). The final structures comprise Leu28–Leu353, 400 water molecules and a
zinc ion in Zn-Is-QC, with the first three N-terminal residues
being excluded from the models owing to high flexibility.
The Is-QC structure exhibits the typically globular and
mixed / scaffold of type II QCs (Fig. 4a). The structure
displays an open sandwich topology, established by a central
six-stranded (1–5 and 8) -sheet flanked by two (6 and
8) and six (1–5 and 9) -helices on the concave and
convex sides, respectively, with one edge of the -sheet being
sealed by an -helix (7) and two antiparallel -strands (6
and 7). The central -sheet is twisted, consisting of five
parallel (1, 3–5 and 8) and one antiparallel (2) strands.
Notably, the two -strands 6 and 7 could only be identified
in the structure of Drosophila mitochondria-resident QC and
not in other structures of type II QCs (Koch et al., 2012). In
addition, there are four short 310-helices adjacent to the
N-terminus of 5, 7 and 9 and the C-terminus of 6 (Figs. 4a
and 5). Surprisingly, in addition to the conserved disulfide
bridge Cys127–Cys149 near the zinc-binding site, Is-QC is
unique in that it possesses two extra disulfide bonds: Cys96–
Cys109 and Cys120–Cys218 (Fig. 4a). Although the Cys127–
Cys149 bond was not formed in the present structure since the
protein was produced in an E. coli expression system, we
noticed that two extra disulfide bridges Cys96–Cys109 and
Cys120–Cys218 were formed, as shown by clear electron
Huang et al.
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Figure 5
Structure-based sequence alignment of Is-QC with secreted QCs from human, mouse and Drosophila. The secondary-structural elements are illustrated
on the basis of the refined structure of Is-QC. The completely conserved residues are shaded in black. The metal-coordinated residues are marked with
grey balls. The three disulfide bridges Cys96–Cys109, Cys120–Cys218 and Cys127–Cys149 are marked with green, red and grey triangles, respectively.
The segments with notable conformation change between these QC structures, as described in the text, are boxed in blue, and the segment with an eightresidue insertion in Is-QC is boxed in red. The PDB codes of these structures are as follows: Is-QC, 4mhn; human sQC, 2afm; mouse sQC, 3si1;
Drosophila sQC, 4f9u.

densities (Supplementary Fig. S11). Cys96–Cys109 connects
strands 1 and 2, while Cys120–Cys218 shields the vertex of
the central -sheet; thus, it is reasonable to assume that these
two disulfide bridges help to stabilize the central -sheet of
Is-QC.

produced the D144A mutant of Is-QC and found that 11%
of the enzymatic activity was retained, although a significant
conformational change was detected by circular-dichroism
spectroscopy (Supplementary Fig. S4), strengthening our
finding that the reaction catalyzed by Is-QC is metal-independent.

3.4. Structures of the zinc-binding site

The putative catalytic centre and the conserved zincbinding residues Asp144, Glu184 and His322 are located in the
unstructured loops near the C-terminal edge of the central
parallel strands 3–5 (Figs. 4a and 5). In Zn-Is-QC, the
bound zinc forms a tetrahedral coordination geometry with
Asp144 O2 (2.03 Å), Glu184 O"2 (1.84 Å), His322 N"2
(1.98 Å) and a water molecule (1.90 Å) (Fig. 4b and Supplementary Fig. S2). In apo-Is-QC, the electron density for zinc
disappeared and a new hydrogen bond was formed between
Glu184 O"2 and His322 N"2 (2.83 Å; Fig. 4c). Consistently,
when Zn-Is-QC was co-crystallized with 1 mM EDTA or when
the crystals of Zn-Is-QC were soaked in buffer with 1 mM
EDTA, the electron density for zinc clearly disappeared
(Supplementary Fig. S3), indicating that the bound zinc in IsQC was removed by EDTA. On superimposing the structures
of Zn-Is-QC and apo-Is-QC, no significant conformational
change was observed (r.m.s. deviation of 0.184 Å for all C
atoms), apart from a slight movement of the side-chain
carboxylic group of Glu184 (Fig. 4d). Furthermore, we
1
Supporting information has been deposited in the IUCr electronic archive
(Reference: DW5081).
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3.5. Comparison with the reported structures of mammalian
and Drosophila sQCs

In spite of limited sequence identity (40–43%), the Is-QC
structure shares a highly conserved scaffold with the reported
structures of human, mouse and Drosophila sQCs (Huang,
Liu, Cheng et al., 2005; Koch et al., 2012; Ruiz-Carrillo et al.,
2011), as shown by the small r.m.s. deviations of 1.118, 1.269
and 1.025 Å for all C atoms, respectively. Notable conformational changes were observed in four segments: Leu132–
Thr138 (referring to the sequence of Is-QC), Asp208–Gln227,
Leu276–Asn284 and Ser290–Ile295 (Figs. 5 and 6a). Of these
segments, the largest loop movement was found at Asp208–
Gln227 owing to an eight-residue insertion in Is-QC (Fig. 5,
red box). The insert forms a 310-helix at the vertex of the
structure and introduces an extra disulfide bridge, Cys120–
Cys218, in the molecule to stabilize the central -sheet (Figs. 4a
and 6b). As a consequence, several loops adjacent to the
disulfide bridge, such as Thr168–Gly172 and Ser211–Ile224,
became ordered and visible, whereas the corresponding loops
in human (Thr183–Lys188), mouse (Ser186–Lys189) and
Drosophila (Gly198–Ala204) sQCs were flexible and were not
Acta Cryst. (2014). D70, 789–801
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observed (Huang, Liu, Cheng et al., 2005; Koch et al., 2012;
Ruiz-Carrillo et al., 2011). Moreover, the structures of human
and mouse sQCs possess an additional N-terminal -helix near
the vertex, but this -helix is not present in Is-QC; instead, the
N-terminus of Is-QC is directed outwards, likely because of
the narrower space caused by the eight-residue insertion
(Supplementary Fig. S5a). In contrast, the first -helix of IsQC is not found in Drosophila sQC because of the shorter
N-terminal sequence (Fig. 5 and Supplementary Fig. S5b).
Similar to human, mouse and Drosophila sQCs, the activesite pocket of Is-QC is narrow but is accessible to solvent
(Fig. 6c). A notable difference between these QCs was
observed in the surface charges around the active-site pocket
owing to residue substitutions; for example, Arg188 in Is-QC
corresponds to His206, His207 and Glu175 in human, mouse

and Drosophila sQCs, respectively. In addition to the zincbinding residues, the catalytic Glu residue (Glu183 in Is-QC)
and the essential hydrogen-bond network (Glu183  Asp297
  Asp238) are completely conserved in Is-QC (Fig. 6d),
suggesting a conserved catalytic mechanism between these
QCs. We further produced the D238A mutant of Is-QC, which
might lead to disruption of the hydrogen-bond network,
resulting in a complete loss of enzymatic activity (Supplementary Fig. S4). This confirms our previous finding regarding
the catalytic role of the hydrogen-bond network (Huang et al.,
2008). The putative hydrophobic substrate-binding pocket is
primarily defined by the residues Trp189, Phe317 and Trp321
(Fig. 6d), reflecting the preference of Is-QC for hydrophobic
and uncharged residues in the second and the third positions
of the substrates, as mentioned above. Another conserved
feature in the active site is a nonproline cis-peptide bond
between Asp144 and Ser145 stabilized by several hydrogen
bonds.

Figure 6
Structural comparison. (a) Superimposition (in stereoview) of the structures of Is-QC (magenta), human sQC (cyan), mouse sQC (yellow) and
Drosophila sQC (green). The segments with notable conformational change between these QC structures are marked with arrowheads. (b) A close-up
view of the structures around the disulfide bridge Cys120–Cys218 of Is-QC. (c) Comparison of the surface-charge distribution on these QC structures.
The charge potentials were calculated with PyMOL (Schrödinger) and are coloured from 68.4 KBT (red) to 68.4 (blue). A notable residue substitution
between these QCs is labelled. (d) A close-up view of the active-site structures of Is-QC (magenta), human sQC (cyan), mouse sQC (yellow) and
Drosophila sQC (green). The catalytically important residues are shown as stick models with numbering referring to the sequence of Is-QC. Note that
the catalytic glutamate residue (Glu183 in Is-QC) and the critical hydrogen-bond network (Glu183  Asp297  Asp238 in Is-QC) are superimposed well
in these QC structures.
Acta Cryst. (2014). D70, 789–801
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3.6. Thermal stability

Since Is-QC contains two extra disulfide bridges compared
with the known structures of type II QCs, we analyzed the
thermal stability of Is-QC using SYPRO Orange dye and
compared it with the stability of human sQC. As shown in
Fig. 7(a), the thermal unfolding transition displayed a
sigmoidal curve. The Tm value of Zn-Is-QC was measured to
be 53 C, slightly higher than that of human sQC (51 C),
implying structural stabilization by the extra disulfide bridges.
Furthermore, apo-Is-QC has a Tm value of 51.5 C, indicating
a little reduction in structural stability upon zinc depletion.
Moreover, the enzymatic activities of these QC samples were
reduced in a temperature-dependent manner and the curves
displayed a sigmoidal shape (Fig. 6b). About 50% of the
activity was retained at 42.6, 41.4 and 40.0 C for Zn-Is-QC,
apo-Is-QC and human sQC, respectively, consistent with the
results obtained from the SYPRO Orange fluorescence assay.
3.7. Metal-independent inhibition by imidazole derivatives

The three imidazole derivatives PBD150, 1-benzylimidazole
and N-!-acetylhistamine were shown to possess remarkable
inhibitory activities towards Zn-Is-QC, with Ki values in the
sub- or mid-micromolar ranges (Table 3), although the effects
are significantly weaker than those towards human sQC
(Huang et al., 2011). Surprisingly, these inhibitors also showed
comparable inhibitory activities towards apo-Is-QC (Table 3),
implying metal-independent binding of the inhibitors to
Is-QC. To elucidate the inhibition mechanism, we determined
the structures of both Zn-Is-QC and apo-Is-QC bound to
PBD150, which were refined to 1.38 and 1.95 Å resolution,
respectively (Table 1). The bound PBD150 in Zn-Is-QC
adopts a similar binding mode as observed in human sQC and
the Drosophila mitochondria-resident QC (Fig. 8a and
Supplementary Fig. S6) (Huang et al., 2011; Koch et al., 2012).
No significant conformational change (r.m.s. deviation of
0.129 Å for all C atoms) was found upon inhibitor binding.
The imidazole ring of PBD150 ligates to the zinc ion and
makes van der Waals contacts with Leu239. The thiourea S

atom forms a hydrogen bond (3.20 Å) to the backbone amide
of Glu296, while the propyl moiety is held in position by the
hydrophobic Trp189, Ile295, Phe317 and Trp321. Moreover,
the dimethoxyphenyl ring is partially stacked with Phe317 and
makes van der Waals contacts with Ile295 and Trp321. The two
methoxy groups are in contact with the backbone amide of
Phe317 via water-mediated hydrogen bonds.
In contrast, the electron density for the bound PBD150 in
apo-Is-QC was broken in some places but was interpretable
(Fig. 8b), probably owing to the lower quality of the data
(Table 1). Similar to that in Zn-Is-QC, the density for the
inhibitor phenyl ring is relatively weak (compare the densities
coloured in red in Figs. 8a and 8b), suggesting that the interaction between the inhibitor phenyl ring and Is-QC is relatively weak. Based on the density that is present, the PBD150
imidazole ring displays a different orientation compared with
that in Zn-Is-QC (Fig. 8c), resulting in the formation of a new
hydrogen bond (2.98 Å) to the indole ring of Trp321 and a
possible electrostatic interaction (3.36 Å) with the carboxylic
group of Asp144 (Fig. 8b). The positioning of PBD150 is
slightly rotated in an anticlockwise direction (Fig. 8c); as a
consequence, the thiourea S atom is closer (2.97 Å) to the
backbone amide of Glu296. Therefore, in spite of the higher
flexibility in the phenyl ring, the electron densities for the
inhibitor thiourea, propyl and imidazole moieties are visible
(Fig. 8b). In addition, the two methoxy groups appeared to
also be involved in water-mediated hydrogen bonds to the
backbone amide of Phe317, as shown by clear electron density.

4. Discussion

Recent studies, particularly those on transgenic mouse models
(Schilling et al., 2008; Nussbaum et al., 2012; Hellvard et al.,
2013; Cynis et al., 2011), have indicated that QCs are potential
drug targets for the treatment of Alzheimer’s disease and
some inflammatory disorders; thus, compounds with the ability
to ligate the active-site zinc of QCs, such as imidazole derivatives, are currently under intense development as QC inhibitors. However, the exact metal content of QCs under
physiological conditions is still unclear,
although it has been more than twentyfive years since the first mammalian
QCs were partially purified from bovine
and porcine pituitary extracts (Fischer
& Spiess, 1987; Busby et al., 1987).
Previously, we proposed a ‘zinc-dependent’ catalytic mechanism for mammalian QCs based on the following findings
(Huang, Liu, Cheng et al., 2005; Huang
et al., 2008). (i) Mammalian QCs share a
highly conserved scaffold and active-site
structure with some binuclear aminopeptidases, such as Aeromonas proteoFigure 7
Thermal stability. (a) Thermal stabilities of Zn-Is-QC, apo-Is-QC and human sQC analyzed using
lytica aminopeptidase (ApAP) and
SYPRO Orange dye (Invitrogen). (b) Enzyme activities of Is-QCs and human sQC at various
Streptomyces griseus aminopeptidase
temperatures. The percentage residual activity at each temperature was calculated on the basis of

(SgAP) (Bzymek & Holz, 2004;
the activity at 25 C as 100%. In both (a) and (b), a typical result from three experiments is
Fundoiano-Hershcovitz et al., 2004).
presented.
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by the fact that the catalytic Glu residue and the zinccoordinated water molecule are completely conserved in the
structures of QCs and aminopeptidases (Huang, Liu, Cheng
et al., 2005) and cooperatively trigger the formation of the
tetrahedral intermediate during catalysis. (ii) Human and
mouse QCs were shown to be susceptible to inhibition by
several heterocyclic metal-chelating agents, imidazole derivatives and some cysteamine derivatives (Schilling, Niestroj et
al., 2003; Schilling et al., 2005). The enzymatic activity of the
‘inactivated’ mammalian QCs, as established
by dialysis against dipicolinic acid or
8-hydroxyquinoline, could be restored by
adding ZnSO4 (Schilling, Niestroj et al.,
2003; Schilling et al., 2005). (iii) A mutation
(H330Q) at one of the zinc-binding residues
of human sQC resulted in a nearly complete
loss of QC activity (Bateman et al., 2001).
However, there is no structural evidence
to support loss of zinc in the ‘inactivated’
mammalian QCs, and no reports have
described the exact quantities of zinc in QCs
treated with EDTA or other metal-chelating
agents. Notably, ApAP and SgAP were
highly susceptible to EDTA inhibition; for
example, only 80 mM EDTA could nearly
abolish the enzymatic activity of SgAP
(Spungin & Blumberg, 1989), which is in
sharp contrast to the refractory properties
of QCs towards EDTA inhibition. In the
present study, we report the first case of an
active QC ‘apoenzyme’, as confirmed by
ICP-MS, high-resolution crystal structure
and enzyme-kinetic analyses. This finding
strongly contradicts the previous conclusions about the role of zinc in QCs.
Furthermore, unlike the previous observation for human sQC (Bateman et al., 2001),
a mutation (D144A) at one of the zincbinding residues of Is-QC did not abolish
the enzyme activity; instead, partial activity
was retained, although the mutant showed a
significant structural change compared with
the wild-type enzyme. These results indicate
that the zinc does not seem to play a catalytic role in Is-QC. Along these lines, the
issue of whether the zinc has a structural
role in Is-QC is raised. Previous results
regarding the structural role of zinc in QCs
are diverse; Ruiz-Carrillo et al. (2011)
Figure 8
reported that the ‘apo-form’ of human sQC
Structures of Is-QC bound to PBD150. (a) A stereoview of the active-site structure of
displayed a remarkably decreased thermal
PBD150-bound Zn-Is-QC. The bound PBD150 is shown as a stick model overlaid with a
stability, whereas no significant change in
simulated-annealing Fo  Fc OMIT map contoured at 2.0 (grey) and 3.0 (red) levels. The
stability was observed for the mitochondriahydrogen bonds and the zinc coordination bonds are shown as dashed lines. (b) A stereoview
of the active-site structure of PBD150-bound apo-Is-QC. The model of PBD150 is overlaid
resident form of Drosophila QC after the
with a simulated-annealing Fo  Fc OMIT map contoured at 1.0 (grey) and 1.5 (red) levels.
zinc was removed (Koch et al., 2012). In the
The hydrogen bonds and a possible electrostatic interaction are shown as dashed lines. (c) A
present study, the zinc in Is-QC apparently
stereoview of superimposition of the PBD150-bound Zn-Is-QC (yellow) and apo-Is-QC
has no structural role, suggesting that the
(green) structures.
These proteases utilize bound zinc ions, usually the tightly
bound zinc ion, to polarize the carbonyl O atom of the scissile
peptide bond of substrates and to stabilize the tetrahedral
intermediate formed during the catalytic process (Lowther &
Matthews, 2002). Therefore, it is reasonable to assume that the
zinc in QCs acts by polarizing the -amide group of the first
Gln residue of the substrate and simultaneously stabilizing the
oxyanion formed by nucleophilic attack of the -nitrogen on
the -carbonyl carbon. This mechanism is further supported
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presence of zinc in Is-QC was owing to nonspecific binding.
It has been well established that the tightly bound zinc in
the active site of ApAP, SgAP and other di-zinc aminopeptidases is essential for catalysis of these enzymes, while the
weakly bound zinc can modulate the enzymatic activity and
substrate specificity (Lowther & Matthews, 2002). To date,
however, no reports have described a structural role for the
zinc ions in aminopeptidases. We noticed that the zinc ions in
aminopeptidases can easily be removed and substituted with
other metals by dialysis methods and that high levels of
enzyme activity can be restored (Lowther & Matthews, 2002),
indicating that there is no significant structural change upon
zinc depletion in aminopeptidases. Since QCs and the di-zinc
aminopeptidases share a common scaffold and active-site
structure, it is reasonable to assume that the zinc in most QCs
has no or little structural role. Moreover, no bacterial type II
QCs have been found thus far in searches of the deposited
genomes of bacteria, and the closest bacterial homologues are
the di-zinc aminopeptidases. This implies that mammalian
QCs and other animal QCs have evolved from the bacterial
zinc aminopeptidases, with the two metal-binding sites being
conserved during the course of evolution. Nevertheless, some
unique structural elements in the active site of QCs have been
created, particularly the catalytically essential hydrogen-bond
network (Huang et al., 2008), which is absolutely conserved
from yeast to human QCs. In this regard, to gain more insights
into the catalysis mechanism of QCs, we should pay more
attention to this unusual hydrogen-bond network. Undoubtedly, this hydrogen-bond network is a good target for QC
inhibitors.
To date, although recombinant human QCs with varied zinc
contents have been reported (Booth et al., 2004; Huang, Liu &
Wang, 2005), the QC activities of these enzymes were
comparable. In the present study, the zinc-bound Is-QC still
showed 65% QC activity when compared with the activity of
apo-Is-QC. In this regard, we cannot rule out the possibility
that both zinc-dependent and zinc-independent catalytic
mechanisms co-exist in the QC family. This is indeed not
surprising since it has been reported that a lysine residue in
plant and bacterial QCs or the zinc ions in some binuclear
aminopeptidases can function as a polarizing group to activate
the susceptible carbonyl group of the substrate during the
catalysis process (Lowther & Matthews, 2002; Wintjens et al.,
2006; Huang et al., 2010). In mammalian QCs, a lysine residue
adjacent to the zinc-binding site, such as Lys144 in human sQC
(Huang, Liu, Cheng et al., 2005), could be a good candidate for
the polarizing group in the absence of bound zinc. However,
this lysine residue is not found in the active site of tick QC, and
mutation of human sQC at this lysine residue did not show a
significant reduction in enzymatic activity (Huang, Liu, Cheng
et al., 2005). Alternatively, two highly conserved histidine
residues, such as His140 and His330 in human sQC and His128
and His322 in Is-QC, could also be candidates, since mutations
of human sQC at each of these two histidine residues inactivated the enzyme (Bateman et al., 2001). The microenvironment of the QC active site is highly acidic, as supported by the
finding that the side-chain carboxylic groups of several
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aspartic acid residues can form hydrogen bonds (Huang et al.,
2008). This suggests that the side-chain imidazole ring of the
histidine residues should be protonated, which eventually
gives them sufficient electrophilicity to activate the susceptible
carbonyl group of the substrate during catalysis.
With regard to the inhibition of QCs by some heterocyclic
metal-chelating agents, Schilling and coworkers reported that
human sQC could be inactivated by dialysis against 5 mM
1,10-phenanthroline or dipicolinic acid, but that 50–60% QC
activity could be restored after repeated dialysis against
chelator-free buffers (Schilling, Niestroj et al., 2003). However,
when the QC sample was dialyzed against buffers containing
1 mM EDTA, no reactivation was observed. In the present
study, a similar reactivation of the QC activity of Is-QC was
observed after the metal-chelating agents were removed using
a size-exclusion column, but the activity could be further
enhanced by adding 1 mM EDTA. These differing observations between human and tick QCs give the zinc an enigmatic
role in this enzyme family. Nevertheless, the strong inhibitory
activities of 1,10-phenanthroline and dipicolinic acid towards
apo-Is-QC may preclude the possibility that the inhibition of
Is-QC is owing to zinc depletion. In fact, the efficacies of 1,10phenanthroline and dipicolinic acid towards QCs are significantly weaker than those towards the zinc-dependent ApAP
and SgAP. For instance, 0.1 mM 1,10-phenanthroline caused a
nearly complete loss of aminopeptidase activity in ApAP and
SgAP (Spungin & Blumberg, 1989; Prescott et al., 1983),
whereas greater than 50% activity was retained by Is-QC and
human sQC (Schilling, Niestroj et al., 2003). Based on these
findings, 1,10-phenanthroline and dipicolinic acid might be
able to bind QCs in a reversible manner, probably binding at
the hydrophobic substrate-binding pocket, since the pocket
can accommodate the hydrophobic methoxyphenyl ring of
PBD150 well. This may be supported by the fact that the
tricyclic 1,10-phenanthroline has an effect stronger by one
order of magnitude than the monocyclic dipicolinic acid
towards QCs.
Finally, we report the zinc-independent inhibition of QCs by
imidazole-derived inhibitors for the first time, although these
inhibitors were shown to be able to bind the active-site zinc of
QCs. The inhibitor PBD150 bound to Zn-Is-QC exhibited a
binding mode similar to that in human sQC (Huang et al.,
2011), in spite of a weaker inhibitory activity towards Is-QC.
Surprisingly, in the absence of zinc the inhibitor showed a
similar orientation except for its imidazole ring, which forms a
new hydrogen bond and a possible electrostatic interaction
with Is-QC. This finding indicates that the zinc coordination of
the inhibitor imidazole ring can be replaced by other interactions. In addition, we noticed that the electron densities at
the inhibitor thiourea, propyl and imidazole moieties are
stronger in both the Zn-bound and apo Is-QC structures,
implying that these groups contribute tighter interactions with
Is-QC which are critical for the inhibitory potency of the
inhibitor.
In conclusion, we present the first case of a metal-independent QC and describe the metal-independent inhibition of
QCs by imidazole-derived inhibitors for the first time. Because
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research papers
the black-legged tick is an important vector of human
pathogens and the more active ‘apo-form’ of Is-QC is a good
target of QC inhibitors, our results not only provide a new way
of thinking about QC catalysis but also suggest new designs of
QC inhibitors for tick control.
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Hoffmann, T., Schilling, S., Demuth, H.-U. & Heiser, U. (2009). J.
Med. Chem. 52, 7069–7080.
Buchholz, M., Heiser, U., Schilling, S., Niestroj, A. J., Zunkel, K. &
Demuth, H.-U. (2006). J. Med. Chem. 49, 664–677.
Burgdorfer, W., Barbour, A. G., Hayes, S. F., Benach, J. L., Grunwaldt,
E. & Davis, J. P. (1982). Science, 216, 1317–1319.
Busby, W. H. Jr, Quackenbush, G. E., Humm, J., Youngblood, W. W.
& Kizer, J. S. (1987). J. Biol. Chem. 262, 8532–8536.
Bzymek, K. P. & Holz, R. C. (2004). J. Biol. Chem. 279, 31018–31025.
Chen, Y.-L., Huang, K.-F., Kuo, W.-C., Lo, Y.-C., Lee, Y.-M. & Wang,
A. H.-J. (2012). Biochem. J. 442, 403–412.
Cynis, H. et al. (2011). EMBO Mol. Med. 3, 545–558.
Cynis, H., Rahfeld, J.-U., Stephan, A., Kehlen, A., Koch, B.,
Wermann, M., Demuth, H.-U. & Schilling, S. (2008). J. Mol. Biol.
379, 966–980.
Cynis, H., Scheel, E., Saido, T. C., Schilling, S. & Demuth, H.-U.
(2008). Biochemistry, 47, 7405–7413.
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.
Engh, R. A. & Huber, R. (1991). Acta Cryst. A47, 392–400.
Fischer, W. H. & Spiess, J. (1987). Proc. Natl Acad. Sci. USA, 84,
3628–3632.
Fundoiano-Hershcovitz, Y., Rabinovitch, L., Langut, Y., Reiland, V.,
Shoham, G. & Shoham, Y. (2004). FEBS Lett. 571, 192–196.
Goren, H. J., Bauce, L. G. & Vale, W. (1977). Mol. Pharmacol. 13,
606–614.
Hellvard, A., Maresz, K., Schilling, S., Graubner, S., Heiser, U.,
Jonsson, R., Cynis, H., Demuth, H.-U., Potempa, J. & Mydel, P.
(2013). J. Infect. Dis. 207, 768–777.

Acta Cryst. (2014). D70, 789–801

Huang, K.-F., Liaw, S.-S., Huang, W.-L., Chia, C.-Y., Lo, Y.-C., Chen,
Y.-L. & Wang, A. H.-J. (2011). J. Biol. Chem. 286, 12439–12449.
Huang, K.-F., Liu, Y.-L., Cheng, W.-J., Ko, T.-P. & Wang, A. H.-J.
(2005). Proc. Natl Acad. Sci. USA, 102, 13117–13122.
Huang, K.-F., Liu, Y.-L. & Wang, A. H.-J. (2005). Protein Expr. Purif.
43, 65–72.
Huang, K.-F., Wang, Y.-R., Chang, E.-C., Chou, T.-L. & Wang,
A. H.-J. (2008). Biochem. J. 411, 181–190.
Huang, W.-L., Wang, Y.-R., Ko, T.-P., Chia, C.-Y., Huang, K.-F. &
Wang, A. H.-J. (2010). J. Mol. Biol. 401, 374–388.
Koch, B., Kolenko, P., Buchholz, M., Carrillo, D. R., Parthier, C.,
Wermann, M., Rahfeld, J.-U., Reuter, G., Schilling, S., Stubbs, M. T.
& Demuth, H.-U. (2012). Biochemistry, 51, 7383–7392.
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M.
(1993). J. Appl. Cryst. 26, 283–291.
Lou, Y.-C., Huang, Y.-C., Pan, Y.-R., Chen, C. & Liao, Y.-D. (2006). J.
Mol. Biol. 355, 409–421.
Lowther, W. T. & Matthews, B. W. (2002). Chem. Rev. 102, 4581–4608.
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner,
R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011).
Acta Cryst. D67, 355–367.
Neupert, S., Russell, W. K., Predel, R., Russell, D. H., Strey, O. F.,
Teel, P. D. & Nachman, R. J. (2009). J. Proteomics, 72, 1040–1045.
Nussbaum, J. M. et al. (2012). Nature (London), 485, 651–655.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326.
Perrakis, A., Morris, R. & Lamzin, V. S. (1999). Nature Struct. Biol. 6,
458–463.
Prescott, J. M., Wagner, F. W., Holmquist, B. & Vallee, B. L. (1983).
Biochem. Biophys. Res. Commun. 114, 646–652.
Rodgers, S. E. & Mather, T. N. (2007). Emerg. Infect. Dis. 13, 633–635.
Ruiz-Carrillo, D., Koch, B., Parthier, C., Wermann, M., Dambe, T.,
Buchholz, M., Ludwig, H.-H., Heiser, U., Rahfeld, J.-U., Stubbs,
M. T., Schilling, S. & Demuth, H.-U. (2011). Biochemistry, 50, 6280–
6288.
Schilling, S., Cynis, H., von Bohlen, A., Hoffmann, T., Wermann, M.,
Heiser, U., Buchholz, M., Zunkel, K. & Demuth, H.-U. (2005).
Biochemistry, 44, 13415–13424.
Schilling, S., Hoffmann, T., Manhart, S., Hoffmann, M. & Demuth,
H.-U. (2004). FEBS Lett. 563, 191–196.
Schilling, S., Hoffmann, T., Rosche, F., Manhart, S., Wasternack, C. &
Demuth, H.-U. (2002). Biochemistry, 41, 10849–10857.
Schilling, S., Lindner, C., Koch, B., Wermann, M., Rahfeld, J.-U., von
Bohlen, A., Rudolph, T., Reuter, G. & Demuth, H.-U. (2007).
Biochemistry, 46, 10921–10930.
Schilling, S., Manhart, S., Hoffmann, T., Ludwig, H.-H., Wasternack,
C. & Demuth, H.-U. (2003). Biol. Chem. 384, 1583–1592.
Schilling, S., Niestroj, A. J., Rahfeld, J.-U., Hoffmann, T., Wermann,
M., Zunkel, K., Wasternack, C. & Demuth, H.-U. (2003). J. Biol.
Chem. 278, 49773–49779.
Schilling, S. et al. (2008). Nature Med. 14, 1106–1111.
Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G.,
Willbold, D., Funke, S. A., Schilling, S. & Demuth, H.-U. (2009).
Biochemistry, 48, 7072–7078.
Segel, I. H. (1993). Enzyme Kinetics: Behavior and Analysis of Rapid
Equilibrium and Steady-State Enzyme Systems, pp. 100–118. New
York: John Wiley & Sons.
Spungin, A. & Blumberg, S. (1989). Eur. J. Biochem. 183, 471–477.
Telford, S. R. III, Dawson, J. E., Katavolos, P., Warner, C. K., Kolbert,
C. P. & Persing, D. H. (1996). Proc. Natl Acad. Sci. USA, 93, 6209–
6214.
Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25.
Wintjens, R., Belrhali, H., Clantin, B., Azarkan, M., Bompard, C.,
Baeyens-Volant, D., Looze, Y. & Villeret, V. (2006). J. Mol. Biol.
357, 457–470.

Huang et al.



Glutaminyl cyclase

801

